Deniz Sahin

Deniz Sahin

Auto-generated profile, based on publicly available information

Deniz Sahin

Kocaeli University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
FDFazilet Dede
Fazilet Dede
STSabriye Karadenizli Taşkın
Sabriye Karadenizli Taşkın
OOOzgur Doga Ozsoy
Ozgur Doga Ozsoy
CECeyla Eraldemir
Ceyla Eraldemir
DSDeniz Sahin
Deniz Sahin
NANurbay Ates
Nurbay Ates

16 June 2021 in Clinical and Experimental Pharmacology and Physiology
Verified
Journal Article
Closed access
PDF file
STSabriye Karadenizli Taşkın
Sabriye Karadenizli Taşkın
DŞDeniz Şahin
Deniz Şahin
NANurbay Ateş
Nurbay Ateş

23 June 2025 in Reproductive Sciences
Verified
Journal Article
Open access
PDF file
ZKZeynep Ece Utkan Korun
Zeynep Ece Utkan Korun
SGSemil Selcen Gocmez
Semil Selcen Gocmez
SFSelenay Furat
Selenay Furat
KSKubra Kavram Sarihan
Kubra Kavram Sarihan
CECeyla Eraldemir
Ceyla Eraldemir
SYSule Yildiz
Sule Yildiz
Alchemilla vulgaris has traditionally been used to treat gynecologic diseases. The anti-inflammatory and vasorelaxant effects of the extract of A. vulgaris (AVE) have been reported in previous studies. This study aimed to investigate the effects of A. vulgaris on PCOS, one of the most common metabolic disorders in adult women of reproductive age, accompanied by inflammation and vascular endothelial dysfunction, in an experimental animal model. Three groups of prepubertal female Wistar rats were established: PCOS, Control, and PCOS + AVE groups. Subcutaneous dehydroepiandrosterone (DHEA) was administered for 35 days to the PCOS and PCOS + AVE groups. The rats in the PCOS + AVE group were orally administered AVE (50 mg/100 g bw/day) for 35 days. Systemic blood pressure, vascular endothelial function, ovarian morphology, and endocrine biomarker levels were measured at the end of the experiment. TNF-α levels were also evaluated in the thoracic aorta and ovaries. Hormonal imbalances, ovarian morphological changes, and endothelial dysfunction were observed in the PCOS group, which returned to the controls after AVE treatment. Furthermore, AVE attenuated the aortic and ovarian levels of TNF-α in the PCOS group. Our study suggests that AVE may have beneficial effects in the treatment of PCOS due to its anti-inflammatory and vasculoprotective properties. Graphical Abstract

12 December 2018 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
EGErsöz Gonca
Ersöz Gonca
FBFigen Barut
Figen Barut
DŞDeniz Şahi̇n
Deniz Şahi̇n
Background/aim: Epileptic seizure leads to sudden unexpected death in epilepsy (SUDEP) among affected patients. The causes of SUDEP are still unclear. The aim of this study was to research the effect of epilepsy on myocardial injury and arrhythmias during experimentally induced acute myocardial ischemia. Materials and methods: Wistar albino rats were divided into four groups: sham, pentylentetrazole (PTZ) + sham, ischemia, and PT% + ischemia groups. PTZ (65 mg/kg, ip) was given 2 h before ischemia. Seizure scoring was conducted by evaluating the PTZ-induced behavioral changes in the rats. The left main coronary artery was ligated in anesthetized rats for 30 min. The incidence and the number of ventricular arrhythmias were determined. Histopathological scoring was performed for tissue injury by using a microscope. Results: Seizure scores were not different among the groups (P > 0.05). The incidence and number of ventricular tachycardia (VT) episodes were significantly higher in the PTZ + ischemia group than in the ischemia group (P < 0.05). More prominent myocardial damage was observed in the PTZ + ischemia group than in the other groups (histopathological scores: PTZ + ischemia; 2.5 +/- 0.5 versus ischemia; 1.2 + 0.4, P < 0.05). Conclusion: PTZ-induced seizure in rats increased myocardial injury and the incidence and number of VT episodes in myocardial ischemia. These results reveal that seizure in epilepsy patients may increase ventricular arrhythmia and myocardial injury during heart attack.

17 March 2026 in Istanbul University Journal of Health Sciences Research
Verified
Journal Article
Closed access
DADuygu Aydemir
Duygu Aydemir
STSabriye Karadenizli Taşkın
Sabriye Karadenizli Taşkın
AAAyşe Seda Akdemir
Ayşe Seda Akdemir
ŞÖŞule Beyhan Özdaş
Şule Beyhan Özdaş
FDFatma Kaya - Dağıstanlı
Fatma Kaya - Dağıstanlı
DŞDeniz Şahin
Deniz Şahin
Objective: This study aimed to evaluate the effects of chronic low-dose mercury exposure during gestation and lactation on the pancreatic endocrine architecture and function in epileptic WAG/Rij rats, elucidating the potential link between developmental toxicant exposure and later metabolic-neural comorbidity.Materials and Methods: Pregnant WAG/Rij rats received intramuscular injections of mercuric chloride (initial dose, 4.6 μg/kg; maintenance dose, 0.07 μg/kg/day) throughout gestation and lactation. The offspring were assessed at postnatal month 5. Body weight and fasting blood glucose were measured. Pancreatic tissues were harvested for histopathological assessment, immunohistochemistry (insulin, glucagon, somatostatin), and Western blotting for quantitative protein expression. Statistical analyses were performed using the Student’s t-test (GraphPad Prism 9.0).Results: Mercury-exposed offspring exhibited significantly elevated body weight (p<0.05) and fasting blood glucose levels (p<0.0001) relative to controls. Immunohistochemical analysis revealed a marked reduction in insulin-positive increase in the numbers of glucagon- and somatostatin-positive cells within the islets. Western blot data confirmed decreased β-actin-normalised insulin expression alongside increased glucagon and somatostatin protein levels. These results indicate pronounced endocrine disruption and β-cell dysfunction following exposure to mercury during the perinatal period.Conclusion: Chronic developmental exposure to low-dose mercury profoundly disrupts pancreatic endocrine homeostasis in epileptic rats, characterized by β-cell depletion and systemic hyperglycemia. These findings support the developmental origins of the health and disease framework and address that early-life mercury exposure may predispose patients to long-term metabolic and neurological comorbidities. Further investigations should focus on the molecular mechanisms, particularly oxidative stress, mitochondrial dysfunction, and the perturbation of calcium signalling, that mediate mercury-induced cell injury.